Gilead's coronavirus treatment remdesivir to cost $3,120 per U.S. patient with private insurance
June 29, 20205 min read937 words
Published: June 29, 2020  |  5 min read937 words
Key PointsGilead CEO Daniel O'Day on remdesivir pricing and ensuring access to treatment announced Monday the much-anticipated pricing for its treatment remdesivir, saying it will cost hospitals $3,120 for a typical U.S. patient with commercial insurance.The company announce...
Gilead's coronavirus treatment remdesivir to cost $3,120 per U.S. patient with private insurance Read more

No article scores yet.

There are no critic or public scores for this article yet.
critic reviews: 0
public reviews: 0
No reviews
img-contested
57%
critic score
28 reviews
img-trusted
68%
public score
88 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
0 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
0 reviews

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.